The osterix transcription factor down-regulates interleukin-1 alpha expression in mouse osteosarcoma cells

Ying Cao1, Shu-Fang Jia, Geetika Chakravarty

  • 1Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Insights

Osterix (Osx) transcription factor suppresses osteosarcoma bone destruction by down-regulating interleukin-1alpha (IL-1alpha) expression. This Osx-mediated repression of IL-1alpha impacts tumor lytic activity.

Area of Science:

  • Molecular Biology
  • Oncology
  • Bone Biology

Background:

  • K7M2 mouse osteosarcoma cells exhibit lytic tumor formation and lack osterix (Osx).
  • Osx is crucial for osteoblast differentiation and bone formation.
  • Cytokines like IL-1alpha stimulate osteoclast activity, contributing to bone destruction.

Purpose of the Study:

  • To investigate the role of Osx in regulating interleukin-1alpha (IL-1alpha) expression in osteosarcoma cells.
  • To determine the mechanism by which Osx affects IL-1alpha production and its impact on tumor lytic activity.

Main Methods:

  • Transfection of Osx into K7M2 cells.
  • Site-directed mutagenesis and chromatin immunoprecipitation to analyze the IL-1alpha promoter.
  • Small interfering RNA (siRNA) to inhibit Osx in Dunn and DLM8 cell lines.
  • Measurement of IL-1alpha promoter activity and protein production.

Main Results:

  • Osx transfection significantly suppressed IL-1alpha production in K7M2 cells via transcriptional regulation.
  • Osx down-regulated IL-1alpha through an Sp1-binding site on the IL-1alpha promoter.
  • Osx inhibition using siRNA increased IL-1alpha promoter activity and protein production, shifting the phenotype from blastic to lytic.

Conclusions:

  • Osx transcription factor transcriptionally represses IL-1alpha expression in mouse osteosarcoma cells.
  • Osx-mediated down-regulation of IL-1alpha may influence the lytic activity of osteosarcoma tumors.